Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Reinert

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Clinical Microbiology|May 15, 1999
Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patientsH Wisplinghoff, R R Reinert, O Cornely, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2009
Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of ageM Imöhl, R R Reinert, M van der Linden
Journal of Medical Microbiology|October 22, 2004
Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparatorsD J Farrell, S G Jenkins, R R Reinert
The Journal of Antimicrobial Chemotherapy|July 15, 1999
A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniaeR R Reinert, R Lütticken, M Lemperle, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|November 1, 1994
Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patientsR R Reinert, A Kaufhold, O Kühnemund, et al.
Chemotherapy|February 15, 2001
In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in GermanyS Lemmen, A Al-Lahham, R Lütticken, et al.
The Journal of Infection|December 12, 2003
Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000)D Felmingham, D J Farrell, R R Reinert, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1998
In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniaeR R Reinert, M Kresken, V Mechery, et al.
Journal of Clinical Microbiology|November 24, 2006
Globicatella sanguinis is an etiological agent of ventriculoperitoneal shunt-associated meningitisI Seegmüller, M van der Linden, C Heeg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1994
Recurrent systemic pneumococcal infection in an immunocompromised patientR R Reinert, A Büssing, H Kierdorf, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Clinical Microbiology|May 15, 1999
Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patientsH Wisplinghoff, R R Reinert, O Cornely, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2009
Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of ageM Imöhl, R R Reinert, M van der Linden
Journal of Medical Microbiology|October 22, 2004
Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparatorsD J Farrell, S G Jenkins, R R Reinert
The Journal of Antimicrobial Chemotherapy|July 15, 1999
A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniaeR R Reinert, R Lütticken, M Lemperle, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|November 1, 1994
Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patientsR R Reinert, A Kaufhold, O Kühnemund, et al.
Chemotherapy|February 15, 2001
In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in GermanyS Lemmen, A Al-Lahham, R Lütticken, et al.
The Journal of Infection|December 12, 2003
Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000)D Felmingham, D J Farrell, R R Reinert, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1998
In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniaeR R Reinert, M Kresken, V Mechery, et al.
Journal of Clinical Microbiology|November 24, 2006
Globicatella sanguinis is an etiological agent of ventriculoperitoneal shunt-associated meningitisI Seegmüller, M van der Linden, C Heeg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1994
Recurrent systemic pneumococcal infection in an immunocompromised patientR R Reinert, A Büssing, H Kierdorf, et al.
Pageof 6